This article is a correction to:
Microfluidic-based human prostate-cancer-on-chip
Linan Jiang
Hunain Khawaja
Shekha Tahsin2
Tanjia A. Clarkson
Yitshak Zohar- 1Department of Aerospace and Mechanical Engineering, Tucson, AZ, United States
- 2Cancer Biology Graduate Interdisciplinary Program, Tucson, AZ, United States
- 3College of Sciences, Tucson, AZ, United States
- 4Department of Molecular and Cellular Biology, Tucson, AZ, United States
- 5University of Arizona Cancer Center, University of Arizona, Tucson, AZ, United States
A Corrigendum on
Microfluidic-based human prostate-cancer-on-chip
by Jiang L, Khawaja H, Tahsin S, Clarkson TA, Miranti CK and Zohar Y (2024). Front. Bioeng. Biotechnol. 12:1302223. doi: 10.3389/fbioe.2024.1302223
In the published article, there was an error in the Funding statement. The Funding statement was incorrectly written as: “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. LJ, HK, ST, TC, CM, and YZ were supported by funding from NIH/NCI MPI R01 CA254200 as part of the Tissue Engineering Consortium and TACMASR by P30 CA023075 UACC support grant. TC acknowledges partial support by the NIH/NCI U54CA143924 for the Partnership of Native American Cancer Prevention (NACP).” The correct Funding statement appears below:
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. LJ, HK, ST, TC, CM, and YZ were supported by funding from NIH/NCI MPI R01 CA254200 as part of the Tissue Engineering Consortium and TACMASR by P30 CA023075 UACC support grant. TC acknowledges partial support by the NIH/NCI U54CA143924 for the Partnership of Native American Cancer Prevention (NACP). ST acknowledges support by NIH/NCI T32 CA009213.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: organ-on-chip, microfluidics, prostate cancer, stromal fibroblasts, cancer-associated fibroblasts (CAFs), prostate tumor invasion, tumor microenvironment
Citation: Jiang L, Khawaja H, Tahsin S, Clarkson TA, Miranti CK and Zohar Y (2024) Corrigendum: Microfluidic-based human prostate-cancer-on-chip. Front. Bioeng. Biotechnol. 12:1520130. doi: 10.3389/fbioe.2024.1520130
Received: 30 October 2024; Accepted: 01 November 2024;
Published: 12 November 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Jiang, Khawaja, Tahsin, Clarkson, Miranti and Zohar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Linan Jiang, amlhbmdsQGFyaXpvbmEuZWR1